GeoVax Labs (GOVX)
(Real Time Quote from BATS)
$2.63 USD
-0.12 (-4.36%)
Updated Sep 25, 2024 03:36 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
GeoVax Labs Inc. (GOVX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.00 | $20.00 | $8.00 | 409.09% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for GeoVax Labs Inc. comes to $14.00. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 409.09% from the last closing price of $2.75.
Analyst Price Targets (4 )
Broker Rating
GeoVax Labs Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the four recommendations deriving the current ABR, four are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/1/2024 | Noble Financial | Robert Leboyer | Strong Buy | Strong Buy |
7/23/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
7/16/2024 | Roth Capital Partners | Jonathan Aschoff | Not Available | Strong Buy |
6/18/2024 | H.C. Wainwright & Co. | Vernon Bernardino | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 4 |
Average Target Price | $14.00 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 82 of 253 |
Current Quarter EPS Est: | -1.29 |
GOVX FAQs
GeoVax Labs Inc. (GOVX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for GeoVax Labs Inc. (GOVX) is $14.00. The current on short-term price targets is based on 2 reports.
The forecasts for GeoVax Labs Inc. (GOVX) range from a low of $8 to a high of $20. The average price target represents a increase of $409.09 from the last closing price of $2.75.
The current UPSIDE for GeoVax Labs Inc. (GOVX) is 409.09%
Based on short-term price targets offered by four analysts, the average price target for GeoVax Labs Inc. comes to $14.00. The forecasts range from a low of $8.00 to a high of $20.00. The average price target represents an increase of 409.09% from the last closing price of $2.75.